Atra stock forecast.

In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we …

Atra stock forecast. Things To Know About Atra stock forecast.

Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million. hace 6 días ... The trading price of Atara Biotherapeutics Inc (NASDAQ:ATRA) closed lower on Monday, November 27, closing at $0.63, -3.22% lower than its ...Nov 13, 2023 · Atara Biotherapeutics stock price predictions for 2022 using artificial intelligence. How much will Atara Biotherapeutics stock be worth in 2022? Target price in 2022. Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Nov 24, 2023 · Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58.

Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts TMC the metals company Inc. (TMC) Stock Forecast & Price Target

Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts The average Atara Biotherapeutics stock price prediction forecasts a potential upside of 1,854.55% from the current ATRA share price of $0.57. What is ATRA's forecast return on equity (ROE) for 2023-2026? 6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.Nov 24, 2023 · The Atara Biotherapeutics stock price gained 13.93% on the last trading day (Friday, 24th Nov 2023), rising from $0.572 to $0.652. During the last trading day the stock fluctuated 29.65% from a day low at $0.552 to a day high of $0.716. The price has risen in 8 of the last 10 days and is up by 171.54% over the past 2 weeks. Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...

$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...

Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare ConferenceStock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ... About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ... ATRA | Atara Biotherapeutics, Inc. Healthcare NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario . 📊 Technical analysis helps id 📈 …ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock?AC Energy Philippines Inc () Stock Market info Recommendations: Buy or sell AC Energy Philippines stock? Manila Stock Market & Finance report, prediction for the future: You'll find the AC Energy Philippines share forecasts, stock quote and buy / sell signals below.According to present data AC Energy Philippines's ACEN shares and potentially …

Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Astra Space ASTR Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Canoo Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.33. Negative dynamics for Canoo shares will prevail with possible volatility of 5.391%. Pessimistic target level: 0.32. Optimistic target level: 0.34.Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Astra Space ASTR Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The company earned $6.09 billion during the quarter, compared to analyst estimates of $5.70 billion.Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Aug 21, 2023 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%. The forecast for beginning of March 169. Maximum value 188, while minimum 166. Averaged Amazon stock price for month 175. Price at the end 177, change for March 4.73%. Amazon Stock Forecast For Tomorrow, Week, Month. S&P 500 Forecast 2023, 2024, 2025. Amazon stock price predictions for April 2024. The forecast for beginning …

Oct 13, 2023 · Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025?

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million. The ARK ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $45.29 and …Nov 16, 2023 · Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions.10 Wall Street research analysts have issued 1-year price objectives for Rogers Communications' stock. Their RCI.B share price targets range from C$54.00 to C$90.00. On average, they anticipate the company's share price to reach C$71.58 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current …Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Euro To Dollar And Dollar To Euro Forecast 2023, 2024-2026. Brent oil price forecast for May 2024. In the beginning price at 70.62 Dollars. High price 72.77, low 70.61. The average for the month 71.42. The Oil Price forecast at the end of the month 71.69, change for May 1.5%. Oil Price forecast for June 2024.

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Arcutis Biotherapeutics Inc have a median target of 10.00, with a high estimate of ...

Discover historical prices for ATRA stock on Yahoo Finance. View daily, weekly or monthly format back to when Atara Biotherapeutics, Inc. stock was issued.The Trade Desk, Inc. (NASDAQ:TTD) issued its quarterly earnings data on Thursday, November, 9th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.05. The technology company had revenue of $493.27 million for the quarter, compared to the consensus estimate of ...Atara Biotherapeutics Stock Forecast. Is Atara Biotherapeutics Stock Undervalued? The current Atara Biotherapeutics [ ATRA] share price is $0.65. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. ATRA is currently trading in the 10-20% percentile range relative to its historical ... During the last day, the stock moved $0.1000 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 1.24% . Our recommended stop-loss: $6.83 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)Their NVDA share price targets range from $195.00 to $780.00. On average, they predict the company's stock price to reach $588.38 in the next year. This suggests a possible upside of 25.8% from the stock's current price. View analysts price targets for NVDA or view top-rated stocks among Wall Street analysts.On average, Wall Street analysts predict that Atara Biotherapeutics 's share price could reach $11.18 by Nov 10, 2024. The average Atara Biotherapeutics stock price …Find real-time MSFT - Microsoft Corp stock quotes, company profile, news and forecasts from CNN Business.Dec 4, 2023 · The ATRA stock price is -767.69% off its 52-week high price of $5.64 and 69.23% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.67 million shares traded. The 3-month trading volume is 3.89 million shares. The consensus among analysts is that Atara Biotherapeutics Inc ... What's Happening With Atara Biotherapeutics Inc Stock Today? Atara Biotherapeutics Inc (ATRA) stock is trading at $0.65 as of 1:00 PM on Friday, Nov 24, a gain of $0.08, or 13.93% from the previous closing price of $0.57. The stock has traded between $0.55 and $0.72 so far today. Volume today is 7,132,201 compared to average volume of 6,444,546.

Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights.Atara Biotherapeutics Stock Price, News & Analysis (NASDAQ:ATRA) $0.65 -0.01 (-1.52%) (As of 12/1/2023 ET) Compare …Industry. Packaged Software. No executives to display. Corporate headquarters. Ventura, California. Find real-time TTD - Trade Desk Inc stock quotes, company profile, news and forecasts from CNN ...Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $).Instagram:https://instagram. roofing stocksreginald smithbest motorcycle insurance in arizonadrs stocks 2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. forex brokers 500 1 leveragetalos energy stock Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... stock ticker s Nov 13, 2023 · Atara Biotherapeutics stock price predictions for 2022 using artificial intelligence. How much will Atara Biotherapeutics stock be worth in 2022? Target price in 2022. Goldman Sachs Sticks to Its Sell Rating for Atara Biotherapeutics (ATRA) November 9, 2023TipRanks. Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI November 9 ...